Institutional investors hold a majority ownership of AGN through the 91.99% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended March 2013, these large investors purchased a net $581.0 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 2.6 Million shares of Allergan Inc
BLACKROCK ADVISORS LLC Bought 2.4 Million shares of Allergan Inc
JENNISON ASSOCIATES LLC Bought 1.7 Million shares of Allergan Inc